136 related articles for article (PubMed ID: 2120548)
1. In vitro studies on the action of CS-045, a new antidiabetic agent.
Ciaraldi TP; Gilmore A; Olefsky JM; Goldberg M; Heidenreich KA
Metabolism; 1990 Oct; 39(10):1056-62. PubMed ID: 2120548
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glucose transport in cultured muscle cells by novel hypoglycemic agents.
Ciaraldi TP; Huber-Knudsen K; Hickman M; Olefsky JM
Metabolism; 1995 Aug; 44(8):976-81. PubMed ID: 7637655
[TBL] [Abstract][Full Text] [Related]
3. Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb.
Okuno A; Ikeda K; Shiota M; Fujiwara T; Yoshioka S; Sugano T; Horikoshi H
Metabolism; 1997 Jun; 46(6):716-21. PubMed ID: 9186311
[TBL] [Abstract][Full Text] [Related]
4. Effect of troglitazone (Rezulin) on fructose 2,6-bisphosphate concentration and glucose metabolism in isolated rat hepatocytes.
Raman P; Foster SE; Stokes MC; Strenge JK; Judd RL
Life Sci; 1998; 62(8):PL89-94. PubMed ID: 9489515
[TBL] [Abstract][Full Text] [Related]
5. Role of glucose and insulin in thiazolidinedione-induced alterations in hepatic gluconeogenesis.
Raman P; Judd RL
Eur J Pharmacol; 2000 Dec; 409(1):19-29. PubMed ID: 11099696
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte but reduction of liver insulin sensitivity.
Dea MK; Van Citters GW; Ader M; Mittelman SD; Sunehag AL; Bergman RN
Diabetes; 2000 Dec; 49(12):2087-93. PubMed ID: 11118011
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes.
Bähr M; Spelleken M; Bock M; von Holtey M; Kiehn R; Eckel J
Diabetologia; 1996 Jul; 39(7):766-74. PubMed ID: 8817100
[TBL] [Abstract][Full Text] [Related]
8. Suppression of hepatic gluconeogenesis in long-term Troglitazone treated diabetic KK and C57BL/KsJ-db/db mice.
Fujiwara T; Okuno A; Yoshioka S; Horikoshi H
Metabolism; 1995 Apr; 44(4):486-90. PubMed ID: 7723671
[TBL] [Abstract][Full Text] [Related]
9. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.
Park KS; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Nikoulina SE; Henry RR
J Clin Endocrinol Metab; 1998 May; 83(5):1636-43. PubMed ID: 9589670
[TBL] [Abstract][Full Text] [Related]
10. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats.
Fulgencio JP; Kohl C; Girard J; Pégorier JP
Diabetes; 1996 Nov; 45(11):1556-62. PubMed ID: 8866561
[TBL] [Abstract][Full Text] [Related]
11. Effect of troglitazone (CS-045) and bezafibrate on glucose tolerance, liver glycogen synthase activity, and beta-oxidation in fructose-fed rats.
Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Itabashi A; Ishii J
Metabolism; 1995 Dec; 44(12):1626-30. PubMed ID: 8786734
[TBL] [Abstract][Full Text] [Related]
12. Acute non-insulin-like stimulation of rat muscle glucose metabolism by troglitazone in vitro.
Fürnsinn C; Neschen S; Noe C; Bisschop M; Roden M; Vogl C; Schneider B; Waldhäusl W
Br J Pharmacol; 1997 Dec; 122(7):1367-74. PubMed ID: 9421284
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone enhances differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes.
Tafuri SR
Endocrinology; 1996 Nov; 137(11):4706-12. PubMed ID: 8895337
[TBL] [Abstract][Full Text] [Related]
14. Troglitazone (CS-045) inhibits beta-cell proliferation rate following stimulation of insulin secretion in HIT-T 15 cells.
Ohtani KI; Shimizu H; Sato N; Mori M
Endocrinology; 1998 Jan; 139(1):172-8. PubMed ID: 9421412
[TBL] [Abstract][Full Text] [Related]
15. Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells.
Kausch C; Krützfeldt J; Witke A; Rettig A; Bachmann O; Rett K; Matthaei S; Machicao F; Häring HU; Stumvoll M
Biochem Biophys Res Commun; 2001 Jan; 280(3):664-74. PubMed ID: 11162573
[TBL] [Abstract][Full Text] [Related]
16. Effects of troglitazone and metformin on glucose and lipid metabolism: alterations of two distinct molecular pathways.
Lenhard JM; Kliewer SA; Paulik MA; Plunket KD; Lehmann JM; Weiel JE
Biochem Pharmacol; 1997 Oct; 54(7):801-8. PubMed ID: 9353134
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of CS-045, a new antidiabetic agent, on insulin secretion in the remnant pancreas after 90% pancreatectomy in rats.
Inoue Y; Tanigawa K; Nakamura S; Xu G; Kawaguchi M; Kato Y; Tamura K
Diabetes Res Clin Pract; 1995 Jan; 27(1):19-26. PubMed ID: 7781490
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone (CS-045) normalizes hypertriglyceridemia and restores the altered patterns of glucose-stimulated insulin secretion in dyslipidemic rats.
Chicco A; Basabe JC; Karabatas L; Ferraris N; Fortino A; Lombardo YB
Metabolism; 2000 Oct; 49(10):1346-51. PubMed ID: 11079827
[TBL] [Abstract][Full Text] [Related]
19. Troglitazone directly inhibits CO(2) production from glucose and palmitate in isolated rat skeletal muscle.
Fürnsinn C; Brunmair B; Neschen S; Roden M; Waldhäusl W
J Pharmacol Exp Ther; 2000 May; 293(2):487-93. PubMed ID: 10773019
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism.
Davies GF; Khandelwal RL; Roesler WJ
Biochim Biophys Acta; 1999 Aug; 1451(1):122-31. PubMed ID: 10446394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
